Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

ALOSETRON HCL 0.5 MG TABLET

Alosetron
$2.2198per EA

Strength

.5 mg/1

Manufacturer

Lifestar Pharma LLC

NDC

70756070230

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ALOSETRON HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213614

On Market Since

9/14/2020

Pharmacological Classes

Serotonin 3 Receptor Antagonists
Serotonin-3 Receptor Antagonist

Price History

1W

0.0%

1M

+0.1%

3M

-9.2%

6M

-6.4%

1Y

-3.8%

3Y

-34.2%

5Y

-71.9%

All

-82.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

ONDANSETRON HCL 4 MG TABLET
Generic
63304045830•Sun Pharmaceutical Industries Inc.
$0.0563
per EA
ONDANSETRON HCL 4 MG TABLET
Generic
00904655161•Major Pharmaceuticals
$0.0633
per EA
ONDANSETRON HCL 4 MG TABLET
Generic
16714015901•NorthStar Rx LLC
$0.0633
per EA
ONDANSETRON HCL 4 MG TABLET
Generic
45963053830•Actavis Pharma, Inc.
$0.0633
per EA
ONDANSETRON HCL 4 MG TABLET
Generic
50268062115•AvPAK
$0.0633
per EA
ONDANSETRON HCL 4 MG TABLET
Generic
55111015330•Dr. Reddy's Laboratories Inc.
$0.0633
per EA
ONDANSETRON HCL 4 MG TABLET
Generic
57237007530•Rising Pharma Holdings Inc.
$0.0633
per EA
ONDANSETRON HCL 4 MG TABLET
Generic
57237007550•Rising Pharma Holdings Inc.
$0.0633
per EA
ONDANSETRON HCL 4 MG TABLET
Generic
62135035005•Chartwell RX LLC
$0.0633
per EA
ONDANSETRON HCL 4 MG TABLET
Generic
62135035030•Chartwell RX LLC
$0.0633
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy